Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | BHVN |
---|---|---|
09:32 ET | 6446 | 56.75 |
09:34 ET | 1595 | 56.31 |
09:36 ET | 300 | 56.31 |
09:38 ET | 1547 | 55.8026 |
09:39 ET | 2243 | 55.688 |
09:41 ET | 12250 | 55.5701 |
09:43 ET | 2194 | 55.6 |
09:45 ET | 2550 | 55.56 |
09:48 ET | 5035 | 55.5 |
09:52 ET | 3800 | 55.4001 |
09:54 ET | 1388 | 55.31 |
09:56 ET | 1040 | 55.43 |
09:57 ET | 1114 | 55.33 |
09:59 ET | 500 | 55.25 |
10:01 ET | 500 | 55.4 |
10:03 ET | 500 | 55.48 |
10:06 ET | 2193 | 55.5 |
10:08 ET | 980 | 55.25 |
10:10 ET | 2761 | 55.205 |
10:12 ET | 1000 | 55.14 |
10:14 ET | 1207 | 55.03 |
10:15 ET | 2500 | 55.216 |
10:17 ET | 300 | 55.19 |
10:19 ET | 200 | 55.24 |
10:21 ET | 1300 | 55.295 |
10:24 ET | 1701 | 55.4 |
10:26 ET | 2774 | 55.55 |
10:28 ET | 1816 | 55.5097 |
10:30 ET | 1186 | 55.55 |
10:32 ET | 1609 | 55.56 |
10:33 ET | 9711 | 55.46 |
10:35 ET | 5499 | 55.55 |
10:37 ET | 4168 | 55.57 |
10:39 ET | 2237 | 55.58 |
10:42 ET | 2723 | 55.53 |
10:44 ET | 540 | 55.55 |
10:46 ET | 3557 | 55.49 |
10:48 ET | 1436 | 55.42 |
10:50 ET | 1600 | 55.2 |
10:51 ET | 620 | 55.17 |
10:53 ET | 916 | 55.065 |
10:55 ET | 701 | 55.035 |
10:57 ET | 701 | 55.045 |
11:00 ET | 590 | 55.08 |
11:02 ET | 4095 | 55 |
11:04 ET | 1398 | 55.095 |
11:06 ET | 950 | 55.22 |
11:08 ET | 2100 | 55.4 |
11:09 ET | 207 | 55.385 |
11:11 ET | 1221 | 55.21 |
11:13 ET | 2061 | 55.36 |
11:15 ET | 2444 | 55.46 |
11:18 ET | 1122 | 55.5 |
11:20 ET | 525 | 55.36 |
11:22 ET | 2372 | 55.54 |
11:24 ET | 3148 | 55.49 |
11:26 ET | 2447 | 55.44 |
11:27 ET | 1222 | 55.5389 |
11:29 ET | 406 | 55.51 |
11:31 ET | 11283 | 55.55 |
11:33 ET | 600 | 55.54 |
11:36 ET | 935 | 55.5 |
11:38 ET | 9679 | 55.93 |
11:40 ET | 1930 | 55.8161 |
11:44 ET | 800 | 55.72 |
11:45 ET | 2283 | 55.83 |
11:47 ET | 800 | 56 |
11:49 ET | 1008 | 55.96 |
11:51 ET | 900 | 55.82 |
11:54 ET | 1300 | 56.025 |
11:56 ET | 3648 | 56.235 |
11:58 ET | 650 | 56.3 |
12:00 ET | 1702 | 56.2001 |
12:02 ET | 2650 | 56.25 |
12:03 ET | 200 | 56.305 |
12:05 ET | 1200 | 56.28 |
12:07 ET | 754 | 56.24 |
12:09 ET | 1654 | 56.54 |
12:12 ET | 601 | 56.6 |
12:14 ET | 700 | 56.655 |
12:16 ET | 1400 | 56.41 |
12:18 ET | 907 | 56.41 |
12:20 ET | 2853 | 56.45 |
12:21 ET | 100 | 56.405 |
12:23 ET | 1977 | 56.47 |
12:25 ET | 1091 | 56.686 |
12:27 ET | 450 | 56.69 |
12:30 ET | 3024 | 56.47 |
12:32 ET | 100 | 56.5 |
12:34 ET | 4520 | 56.48 |
12:36 ET | 6387 | 56.62 |
12:38 ET | 1111 | 56.43 |
12:39 ET | 1096 | 56.33 |
12:41 ET | 1376 | 56.16 |
12:43 ET | 1556 | 56.18 |
12:45 ET | 500 | 56.17 |
12:48 ET | 1787 | 56.22 |
12:50 ET | 1027 | 56.11 |
12:52 ET | 2310 | 56.29 |
12:54 ET | 918 | 56.31 |
12:56 ET | 100 | 56.355 |
12:57 ET | 2362 | 56.36 |
12:59 ET | 100 | 56.265 |
01:01 ET | 782 | 56.05 |
01:03 ET | 900 | 56.04 |
01:06 ET | 1400 | 55.89 |
01:08 ET | 1744 | 55.925 |
01:10 ET | 400 | 55.915 |
01:12 ET | 1253 | 55.87 |
01:14 ET | 350 | 55.908 |
01:15 ET | 1712 | 55.9 |
01:17 ET | 500 | 55.7 |
01:19 ET | 503 | 55.76 |
01:21 ET | 1501 | 55.725 |
01:24 ET | 512 | 55.635 |
01:26 ET | 4543 | 55.78 |
01:28 ET | 1300 | 55.6 |
01:30 ET | 833 | 55.63 |
01:32 ET | 693 | 55.46 |
01:33 ET | 1200 | 55.445 |
01:35 ET | 300 | 55.43 |
01:39 ET | 520 | 55.32 |
01:42 ET | 3085 | 55.22 |
01:44 ET | 1653 | 55.19 |
01:46 ET | 2566 | 55.1491 |
01:48 ET | 4333 | 55.27 |
01:50 ET | 300 | 55.345 |
01:51 ET | 3052 | 55.32 |
01:53 ET | 1000 | 55.3 |
01:55 ET | 1707 | 55.27 |
01:57 ET | 500 | 55.3 |
02:00 ET | 3621 | 55.27 |
02:02 ET | 1719 | 55.26 |
02:04 ET | 1100 | 55.315 |
02:06 ET | 200 | 55.31 |
02:08 ET | 1983 | 55.49 |
02:09 ET | 100 | 55.505 |
02:11 ET | 1419 | 55.43 |
02:13 ET | 900 | 55.55 |
02:15 ET | 100 | 55.6 |
02:18 ET | 2124 | 55.57 |
02:20 ET | 700 | 55.54 |
02:22 ET | 2935 | 55.4 |
02:24 ET | 1200 | 55.41 |
02:26 ET | 700 | 55.5 |
02:27 ET | 2009 | 55.55 |
02:29 ET | 601 | 55.57 |
02:31 ET | 900 | 55.47 |
02:33 ET | 200 | 55.5 |
02:38 ET | 3047 | 55.47 |
02:40 ET | 1199 | 55.46 |
02:42 ET | 1400 | 55.405 |
02:44 ET | 418 | 55.32 |
02:45 ET | 2301 | 55.37 |
02:47 ET | 1253 | 55.355 |
02:49 ET | 2224 | 55.41 |
02:51 ET | 633 | 55.31 |
02:54 ET | 1815 | 55.36 |
02:56 ET | 1307 | 55.47 |
02:58 ET | 1600 | 55.63 |
03:00 ET | 2878 | 55.52 |
03:02 ET | 2427 | 55.65 |
03:03 ET | 12799 | 55.95 |
03:05 ET | 4992 | 55.95 |
03:07 ET | 800 | 55.72 |
03:09 ET | 2995 | 55.82 |
03:12 ET | 705 | 55.79 |
03:14 ET | 1537 | 55.805 |
03:16 ET | 2731 | 55.75 |
03:18 ET | 400 | 55.57 |
03:20 ET | 2050 | 55.71 |
03:21 ET | 200 | 55.71 |
03:23 ET | 500 | 55.565 |
03:25 ET | 3292 | 55.61 |
03:27 ET | 525 | 55.62 |
03:30 ET | 680 | 55.53 |
03:32 ET | 1500 | 55.38 |
03:34 ET | 2127 | 55.45 |
03:36 ET | 2000 | 55.595 |
03:38 ET | 2114 | 55.625 |
03:39 ET | 1684 | 55.6125 |
03:41 ET | 1006 | 55.65 |
03:43 ET | 2333 | 55.61 |
03:45 ET | 5121 | 55.46 |
03:48 ET | 2635 | 55.23 |
03:50 ET | 6932 | 55.04 |
03:52 ET | 8651 | 55.119 |
03:54 ET | 5763 | 55.03 |
03:56 ET | 21224 | 54.895 |
03:57 ET | 13048 | 54.985 |
03:59 ET | 20590 | 54.69 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Biohaven Ltd | 4.5B | -9.6x | --- |
Immunovant Inc | 4.7B | -17.7x | --- |
Iovance Biotherapeutics Inc | 4.1B | -7.8x | --- |
Nuvalent Inc | 4.8B | -34.8x | --- |
Apogee Therapeutics Inc | 3.8B | -38.2x | --- |
Crinetics Pharmaceuticals Inc | 3.6B | -12.7x | --- |
Biohaven Ltd. is a clinical-stage biopharmaceutical company. The Company is focused on the discovery, development, and commercialization of treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its clinical and preclinical programs include Kv7 ion channel modulation for epilepsy and mood disorders; extracellular protein degradation for immunological diseases; Transient Receptor Potential Melastatin 3 (TRPM3) antagonism for migraine and neuropathic pain; Tyrosine Kinase 2/Janus Kinase 1 (TYK2/JAK1) inhibition for neuroinflammatory disorders; glutamate modulation for obsessive-compulsive disorder (OCD) and spinocerebellar ataxia (SCA); myostatin inhibition for neuromuscular and metabolic diseases, including spinal muscular atrophy (SMA) and obesity; and antibody recruiting, bispecific molecules and antibody drug conjugates (ADCs) for cancer. The Troriluzole is a new chemical entity (NCE) and tripeptide prodrug of the active metabolite, riluzole.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $4.5B |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 81.7M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-5.67 |
Book Value | $5.28 |
P/E Ratio | -9.6x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.